Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Oto
AddedMar 22, 2024
UpdatedJul 3, 2026
Oto

Oto

Seed

Oto offers affordable digital therapy for effective tinnitus management.

HQ
London, Greater London, GB
Founded
2019
Accelerator
Y Combinator logoY CombinatorW22
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to make tinnitus management accessible and affordable, Oto offers digital therapy programs designed to alleviate the symptoms of tinnitus, a condition affecting 1 in 8 people. By leveraging technology, Oto provides an alternative to costly in-person treatments, delivering effective therapy through a digital platform. Their core vision is to democratize access to tinnitus care, ensuring that more individuals can find relief without the financial burden.

Notable affiliated individuals and investors in Oto include experts in audiology and digital health, although specific names are not provided. Key achievements for Oto include the successful development and deployment of their digital therapy programs, which have been well-received by users for their accessibility and effectiveness. Overall, Oto has made a significant impact by providing a cost-effective solution for tinnitus management, improving the quality of life for many sufferers.

Oto - Similar Companies

Jeevam Health logo

Jeevam Health

jeevamhealth.com

Otolith Sound logo

Otolith Sound

otolithlabs.com

Comet Health logo

Comet Health

trycomet.com

Audicus logo

Audicus

audicus.com

OtisHealth logo

OtisHealth

otishealth.net

Otologic Technologies logo

Otologic Technologies

otologictech.com

AudioFocus logo

AudioFocus

audiofocus.io

Audio Bionics logo

Audio Bionics

Rthm logo

Rthm

rthm.com

Harp Health logo

Harp Health

harphealthtech.com

Mindset Health logo

Mindset Health

mindsethealth.com

Therify logo

Therify

therify.co

Dr.Online logo

Dr.Online

dronline.com

Untether Labs logo

Untether Labs

untetherlabs.com

Soundwave Hearing logo

Soundwave Hearing

hearsoundwave.com

Oto - Quick Facts

Who are Oto's competitors?

Companies similar to Oto include Jeevam Health, Otolith Sound, Comet Health and Audicus.

When was Oto founded?

Oto was founded in 2019.

Where is Oto's headquarters located?

Oto's headquarters is located in London, Greater London, GB.

When was Oto's last funding round?

Oto's most recent funding round was for $2.8M (USD) in July 2022.

How much has Oto raised to-date?

As of Jul 13, 2022, Oto has raised a total of $3.3M (USD).

How many employees does Oto have?

Oto has 20 employees as of Feb 24, 2024.

Oto - Classification

Ownership
  • Venture Capital
Technology
  • Telemedicine
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Digital Therapy
Tags
  • Healthtech
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 620000Health Care and Social Assistance
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 8000Health Services
Show 11 more industry codes
NAICS
  • 513200Software Publishers
  • 621300Offices of Other Health Practitioners
  • 621340Offices of Physical, Occupational and Speech Therapists, and Audiologists
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified